# Boehringer lngelheim Therapeutics Gmbh – FDA Inspection, Sep 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/boehringer-lngelheim-therapeutics-gmbh/daae53dd-a5bc-451f-914f-f5badf765783
Source feed: FDA_Inspections

> FDA inspection 1070155 of Boehringer lngelheim Therapeutics Gmbh, September 26, 2018. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070155
- Company Name: Boehringer lngelheim Therapeutics Gmbh
- Inspection Date: 2018-09-26
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brian-d-nicholson/83ea13dd-6753-468a-a0ca-19e3ef4158dd)

Company: https://www.keypedia.com/companies/boehringer-lngelheim-therapeutics-gmbh/40bd4091-12f6-4519-8050-2a8aaedc941a

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8